Answer To Peer, Similarities Less 5%, References 2, APA 6

Condition of Mrs Allen and Treatment

Mrs Allen is a 68-year-old African American whose age is a factor that exposes her to many diseases. The old comes with many challenges one of them been able to follow the doctor’s prescription correctively. Additionally, the patient has been experiencing shortness of breath for the past three. The condition is also called dyspnea which is caused by asthma, anxiety and heart failure condition. Even though there is no single drug that has been listed for shortness of breath, as a medical provider, I recommend Mrs Allen to  Aliskiren is an orally active nonpeptide drug with a half-life of about 24 hours, and is dosed once per day.  It is metabolized by the liver and excreted by the kidneys. Based on the ACC/AHA, If the target blood pressure is not reached within one month after initiating therapy, the dosage of the initial medication should be increased or a second medication should be added (thiazide diuretic, calcium channel blocker, ACE inhibitor, or ARB)

The patient has also experienced lower leg edema pitting 1+, which started two weeks ago. The condition has been diagnosed through a physical examination of Mrs Allen’s medical history. Magnetic resonance imaging and ultrasound exams were further used to diagnosis the disease. In case the patient is suffering from mild edema, the facility can raise the limb in question higher above the heart. Additionally, the diuretics can be used to expel excess fluid in the body. Based on the fact that Mrs Allen cannot afford most of the medications, I recommend her to be taking regular exercises mostly in the morning.

Mrs Allen needs medication given her MI condition. The history of on myocardial Infarction MI for the past one year is evidence that the patient requires medication. If the condition is reduced before it goes high will be one element of saving her life. In efforts to suppress the pain that Mrs Allen is going through, she should take aspirin 81 mg daily.

Reference

https://www.cvpharmacology.com/vasodilator/renin

https://www.aafp.org/afp/2014/1001/p503.pdf